In a landmark move set to reshape the landscape of global wellness and regenerative medicine, European Wellness Biomedical Group and Jilin Hanxing Group have signed a pivotal strategic cooperation agreement. 

Dr Mike Chan (left in the image), Scientist, Founder and Chairman of European Wellness Biomedical Group, and Fang Tie Ji (right in the image), Chairman of Jilin Hanxing Group, a multi-billion dollar conglomerate from Donggang City, Liaoning Province, China, formalised the agreement. 

The agreement outlines plans for a joint venture project to establish a state-of-the-art Regenerative Medicine and Health Complex in Sanya, Hainan, China. This ambitious project is envisioned as a trinity of 'medicine, beauty, and health therapy', positioning itself at the forefront of the global wellness industry.

The partnership will facilitate knowledge exchange and collaborative research, potentially accelerating breakthroughs in regenerative medicine and anti-aging therapies.

The new complex aims to attract health-conscious individuals from around the world, positioning Sanya as a premier destination for medical wellness tourism. In the interim, Sabah (in Malaysia) will see an influx of high-value medical wellness tourists from China.

European Wellness will gain enhanced access to the vast Chinese market, while Jilin Hanxing Group will benefit from European Wellness' global expertise and reputation.